J Refract Surg. 2024 Apr;40(4):e208-e217. doi: 10.3928/1081597X-20240311-01. Epub 2024 Apr 1.
To evaluate spherical intraocular lens (IOL) implantation for cataracts in keratoconic eyes followed by optional refractive toric lens exchange to improve uncorrected visual acuity.
This retrospective study evaluated cataract surgery outcomes in keratoconic eyes. Eyes treated with a spherical IOL targeted for -2.00 diopters (D) either achieved acceptable manifest refraction and desired exchange with a toric IOL (Group 1); achieved satisfactory manifest refraction and chose to use spectacles or contact lenses (Group 2); or did not achieve acceptable refraction and used contact lenses (Group 3). Group 4 had single-stage toric IOL implantation with plano target. Corrected and uncorrected distance visual acuity (CDVA and UDVA) and keratometry were analyzed.
Groups 1 to 4 had 18, 23, 18, and 26 eyes, respectively. A staged toric exchange resulted in significantly better ( = .02) UDVA (mean: 0.15 logMAR; 20/25 Snellen) than initial toric IOL implantation (0.24 logMAR; 20/30 Snellen). All toric IOL exchange eyes achieved 20/30 or better CDVA and 94% had 20/40 or better UDVA. Mean manifest cylinder significantly decreased from 3.39 D before lens exchange to 1.10 D postoperatively.
Initial implantation of a spherical IOL in keratoconic eyes allows basing toric calculations on the manifest refraction, which may be more reliable than keratometry measurements in keratoconic eyes. UDVA after staged toric IOL exchange was significantly better than after initial toric IOL implantation. Importantly, by staging use of toric lenses, the authors avoided cases where patients required a rigid contact lens after a toric IOL was implanted. .
评估在圆锥角膜眼中植入球面人工晶状体(IOL)以治疗白内障,然后选择性地进行屈光性toric IOL 置换以改善未矫正视力。
本回顾性研究评估了圆锥角膜眼中白内障手术的结果。使用目标屈光度为 -2.00 屈光度(D)的球面 IOL 治疗的眼睛获得了可接受的明视屈光度和理想的 toric IOL 置换(第 1 组);获得了满意的明视屈光度并选择使用眼镜或隐形眼镜(第 2 组);或未获得可接受的屈光度并使用隐形眼镜(第 3 组)。第 4 组进行了单阶段 toric IOL 植入术,目标为平光。分析矫正和未矫正远距视力(CDVA 和 UDVA)和角膜曲率。
第 1 至 4 组分别有 18、23、18 和 26 只眼。分期 toric 置换可显著改善(=0.02)UDVA(平均:0.15 logMAR;20/25 Snellen),优于初始 toric IOL 植入术(0.24 logMAR;20/30 Snellen)。所有 toric IOL 置换眼均获得 20/30 或更好的 CDVA,94%的眼获得 20/40 或更好的 UDVA。平均显微微镜柱从 lens 置换前的 3.39 D 显著降低至术后的 1.10 D。
在圆锥角膜眼中初始植入球面 IOL 可基于明视屈光度进行 toric 计算,这可能比圆锥角膜眼中的角膜曲率计测量更可靠。分期 toric IOL 置换后的 UDVA 明显优于初始 toric IOL 植入术后。重要的是,通过分期使用 toric 镜片,作者避免了在植入 toric IOL 后患者需要使用硬性隐形眼镜的情况。